1. Home
  2. ZUMZ vs AVXL Comparison

ZUMZ vs AVXL Comparison

Compare ZUMZ & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

HOLD

Current Price

$27.70

Market Cap

363.1M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.73

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZUMZ
AVXL
Founded
1978
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
363.1M
397.6M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ZUMZ
AVXL
Price
$27.70
$3.73
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$18.00
$22.00
AVG Volume (30 Days)
350.9K
2.8M
Earning Date
12-04-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$916,909,000.00
N/A
Revenue This Year
$5.50
N/A
Revenue Next Year
$1.36
N/A
P/E Ratio
$56.68
N/A
Revenue Growth
2.81
N/A
52 Week Low
$11.31
$2.86
52 Week High
$31.70
$14.44

Technical Indicators

Market Signals
Indicator
ZUMZ
AVXL
Relative Strength Index (RSI) 55.68 35.61
Support Level $28.30 $3.56
Resistance Level $28.84 $4.88
Average True Range (ATR) 1.09 0.33
MACD -0.34 0.10
Stochastic Oscillator 22.75 15.53

Price Performance

Historical Comparison
ZUMZ
AVXL

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: